Design Therapeutics (DSGN) SEC Filings & 10K Form $4.19 +0.04 (+0.96%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$4.19 0.00 (0.00%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Design Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/10/20256:30 AMDesign Therapeutics (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 03/10/20256:10 AMDesign Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/10/20256:16 AMDesign Therapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 01/13/20258:09 AMDesign Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/06/20256:00 PMDesign Therapeutics (Issuer)Jeffries Sean (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/06/20256:00 PMDesign Therapeutics (Issuer)Shah Pratik (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/06/20256:00 PMBurgess Julie (Reporting)Design Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/06/20256:00 PMDesign Therapeutics (Issuer)LAPPE RODNEY W (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/19/20245:30 PMDesign Therapeutics (Issuer)Prasad Deepa (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/13/20245:53 PMDesign Therapeutics (Subject)Logos Global Management LP (Filed by)Form SC 13D/A08/12/20243:30 PMDesign Therapeutics (Issuer)William Arsani (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/09/20243:20 PMDesign Therapeutics (Subject)Logos SPV 1 LP (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 08/05/20247:01 AMDesign Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/05/20247:12 AMDesign Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/25/20243:30 PMDesign Therapeutics (Filer)Form DEF 14A04/25/20243:33 PMDesign Therapeutics (Filer)Form DEFA14A(Data available from 1/1/2016 forward) Remove Ads Related Companies and Tools Related Companies Spyre Therapeutics 10Q Form ARS Pharmaceuticals 10Q Form Nurix Therapeutics 10Q Form Enliven Therapeutics 10Q Form Intellia Therapeutics 10Q Form Qilian International Holding Group 10Q Form Arcus Biosciences 10Q Form Vir Biotechnology 10Q Form Rocket Pharmaceuticals 10Q Form Collegium Pharmaceutical 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:DSGN) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Design Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Design Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DSGN Stock Free DSGN Stock Alerts